Mosquito bed net assembly
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Emerging resistance to pyrethroids in mosquito bed nets threatens the effectiveness of malaria control, as mosquitoes develop resistance to the currently used insecticides, necessitating new designs or approaches to maintain the efficacy of long-lasting insecticidal nets (LLINs).
Innovation Solution
A mosquito bed net assembly featuring a barrier member with a second insecticide located above the bed net, which increases the likelihood of mosquito contacts with an insecticide-treated surface, allowing for the use of non-pyrethroid insecticides that are otherwise barred due to their potency and effectiveness against resistant mosquitoes, while keeping the barrier member distant from humans to prevent exposure.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pyrethroid insecticides are used in bed nets, then mosquito killing effectiveness is improved, but mosquito resistance to pyrethroids increases over time
Solution Approach 1:
The bed net is divided into two distinct zones: a lower zone treated with pyrethroid insecticide and an upper barrier zone treated with a different insecticide class (such as organophosphate or carbamate). This segmentation allows each zone to perform a specific function - the lower zone provides initial protection while the upper zone targets resistant mosquitoes, thereby maintaining killing effectiveness without relying solely on pyrethroids.
Solution Approach 2:
Different insecticide treatments are applied to different regions of the bed net. The lower portion uses pyrethroid while the upper barrier portion uses a non-pyrethroid insecticide. This local differentiation in chemical properties allows the system to address both susceptible and resistant mosquito populations simultaneously, preventing resistance development while maintaining efficacy.
2Reliability
If non-pyrethroid insecticides are applied to the bed net, then effectiveness against resistant mosquitoes is improved, but human exposure risk increases
Solution Approach 1:
The non-pyrethroid insecticide is applied exclusively to the upper barrier zone of the bed net, away from the sleeping area. This localized application ensures that the potent non-pyrethroid chemical is positioned where it can intercept resistant mosquitoes flying above the sleeper, while the lower zone near the human remains treated with safer pyrethroid or untreated, minimizing human exposure risk.
Solution Approach 2:
The solution moves the application of non-pyrethroid insecticide to a different spatial dimension - the vertical upper barrier zone rather than the horizontal sleeping surface. This dimensional relocation allows the use of more potent chemicals in a location where they provide maximum mosquito-killing benefit while minimizing proximity to humans, thus reducing exposure risk.
3Reliability
If a barrier member is added above the bed net, then mosquito contact frequency with insecticide is increased, but device complexity increases
Solution Approach 1:
The barrier member is integrated with the bed net structure itself rather than being a separate suspended component. The upper portion of the bed net is constructed as an elevated barrier zone that forms part of the net's overall structure, eliminating the need for additional suspension mechanisms or separate barrier devices. This merging reduces complexity while maintaining the function of increasing mosquito contact frequency with the insecticide-treated surface.
Data Source
AI summary
Mosquito bed net assembly 10a-h includes a mosquito bed net (12) impregnated with a first insecticide and a barrier member 16a-h located above an upper surface (14) of the bed net (12) and being impregnated with a second insecticide. In use, bed net assembly 16a-h increases the likelihood of delivering a lethal dosage of insecticide to mosquitoes flying in frequently-visited areas of a bed net, without increased attendant health risk to a user.